Health care firm plans to create 114 jobs
SynCare LLC’s expansion hinges on city approval of property tax abatement. The Metropolitan Development Commission is set
to vote on the request Wednesday.
Health Care & Life Sciences
Articles
St. Vincent closes in on new hospital deal
A deal in which St. Vincent Health would buy or lease Bedford’s Dunn Memorial Hospital is in the final stages, according
to the Times-Mail of Bedford. The hospital board held two hours of closed-door talks on May 26, and one board member
predicted a decision within days.
Expert: Reform can improve communities
The much-maligned health care bill provides a huge opportunity for local communities to improve the health of their citizens
and for local health care providers to win bonus payments from federal health insurance programs. That's the message Len
Nichols, a Beltway veteran and health policy expert, will bring to attendees at the All Healthcare is Local conference today.
Genetic testing could spur Erbitux drug sales
The drugmakers are counting on screening for the so-called K-ras gene to spur use of Erbitux in metastatic colorectal cancer.
Lilly grows Alimta’s sales by shrinking market
In 2008, Eli Lilly and Co. asked drug regulators to change the label on Alimta so Lilly could no longer promote it as a treatment
for all patients suffering from non-small-cell lung cancer, but for only about 70 percent of the patients. Since then, sales
of the drug have accelerated, growing a whopping 48 percent last year.
Positron has billion-dollar hopes for medical-imaging scanner
A maker of medical imaging equipment that recently moved its headquarters to Fishers has grand plans to reach $1 billion in
sales and build a multimillion-dollar cyclotron facility in five years. But history shows Positron Corp. has been far better
at losing money than making it.
Cancer researcher battling Semafore in court
Former collaborator alleges firm breached its agreement with him and refused to pay royalty income.
Indianapolis startup attacks Alzheimer’s disease
AgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual
property, and begin learning how to make a drug into a once-a-day pill.
Biopharma fueling boom in refrigerated warehousing
In the past few years, a handful of cold storage facilities have sprouted locally by playing to Indianapolis' strengths
in warehousing and life sciences.
WellPoint pledges two-day hospital stays after mastectomy
In the company's latest response to withering criticism of its breast-cancer policies, WellPoint Inc. said it will pay
for any breast cancer patient to stay two days in a hospital after surgery.
Summit to counsel cities on reform
Now that health reform is law, a local not-for-profit group, Better Healthcare for Indiana, wants to help Indiana community
leaders use the law to slow runaway medical spending while improving the health of their citizens.
Effective stats are new hurdle for U.S. drugmakers
WellPoint Inc.'s announcement of comparative effectiveness research guidelines last week marks a new era for U.S. drugmakers.
The Indianapolis-based health insurer will use studies that compare the effectiveness of one drug against another as a complement
to typical clinical trial research that compares a drug against a placebo sugar pill.
Q&A: Don Stumpp
Don Stumpp, manager of payer contracting at Indianapolis-based physician group American Health Network and president of the Indiana Medical Group Management Association, discussed the impact of the health care reform law on primary care physicians as well as the near-constant threat of a sharp cut in Medicare reimbursement.
Lilly spent $2.3M lobbying in first quarter
Indianapolis-based Eli Lilly and Co. spent about $2.3 million in the first quarter of 2010 lobbying the federal government
on health care reform, Medicare reimbursement and trade issues among other topics.
Moody’s lowers Eli Lilly outlook to ‘negative’
Moody's Investors Service on Friday lowered its rating outlook on drugmaker Eli Lilly and Co. to "negative"
from "table" due in part to the looming expiration of patents protecting key drugs from generic competition.
New estimate says health plan to cost Indiana $2.9B
The estimate released Friday from an outside actuary hired by the state is lower than the actuary’s “worst case scenario”
given two weeks ago.
Eli Lilly invests in $250M Australian venture fund
The unnamed venture fund will be based in Brisbane, and will focus on biotechnology investments in Australia and southeastern
Asia.
Health care suppliers need to think long term, expert says
Companies in the health care supply chain need to engage in more strategic, long-term preparation even as the industry faces
uncertainties and upheaval, MIT expert tells local conference attendees.
UPDATE: Arcadia confirms major growth plans
Arcadia Resources Inc. is planning a $3.9 million expansion of its Indianapolis headquarters and pharmacy operations, the
company said Thursday morning, confirming that it plans to add as many as 930 jobs by 2013.
Drug-spending increase highest in four years
The price increase was fueled by the debate over the health-care overhaul in Washington, D.C., Medco Health Solutions Inc. CEO David Snow said.